VSN Verseon (DI)

TIDMVSN

RNS Number : 9904X

Verseon Corporation

16 August 2018

 
For immediate release  16 August 2018 
 

Verseon Corporation

("Verseon" or the "Company")

Change of Adviser

Fremont, Calif.- Verseon (AIM:VSN), a technology-based pharmaceutical company employing a computer-driven platform to develop a diverse drug pipeline, today announces the appointment of Arden Partners plc as nominated adviser and joint broker to the Company with immediate effect.

- Ends -

For further information, please contact:

 
 Verseon Corporation                              www.verseon.com 
 Sebastian Wykeham                                +1 (510) 225 9000 
 
 Arden Partners (NOMAD and Joint Broker) 
                                                  +44 (0) 20 7614 
            Ruari McGirr / Maria Gomez De Olea     5900 
 Cantor Fitzgerald Europe (Joint Broker) 
                                                  +44 (0) 20 7894 
 Marc Milmo / Phil Davies                          7000 
 
 

For financial and business media enquiries, please contact

 
 Buchanan Communications Ltd (PR Advisers) 
                                              +44 (0) 20 7466 
 Henry Harrison-Topham / Jamie Hooper          5000 
 

About Verseon

Verseon Corporation (www.verseon.com, AIM: VSN) is a technology-based pharmaceutical company that pairs a proprietary, computational drug discovery platform with a comprehensive in-house chemistry and biology workflow to develop novel therapeutics that are unlikely to be found using conventional methods. The Company is applying its platform to a growing drug pipeline and currently has four active drug programs in the areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

APPGUGDILDBBGIL

(END) Dow Jones Newswires

August 16, 2018 02:01 ET (06:01 GMT)

Verseon (LSE:VSN)
Historical Stock Chart
From Apr 2024 to May 2024

Verseon (LSE:VSN)
Historical Stock Chart
From May 2023 to May 2024